July 31, 2023
D.C. News | Tea Leaves
  • Friday, the Federal Trade Commission (FTC) announced its withdrawal of two policy statements outlining its former position on antitrust enforcement in health care markets, echoing a similar decision from the Department of Justice (DOJ) earlier this year. The agencies’ decisions come amid tightened scrutiny of dealmaking within the health care industry. More broadly, the FTC proposed a change to its pre-merger notification requirements that would give regulators more information to review during a deal’s initial waiting period. The proposed changes would nearly quadruple the per-hour filing burden on merging organizations and would hand the agency more fuel with which to block mergers it views as anti-competitive. (Article here)